Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1960 1
1961 1
1962 2
1963 2
1964 3
1965 2
1968 5
1969 6
1970 5
1971 3
1972 6
1973 4
1974 8
1975 3
1976 7
1977 11
1978 11
1979 7
1980 6
1981 6
1982 9
1983 15
1984 9
1985 18
1986 16
1987 19
1988 18
1989 28
1990 36
1991 36
1992 38
1993 27
1994 32
1995 39
1996 44
1997 52
1998 83
1999 75
2000 87
2001 94
2002 108
2003 125
2004 145
2005 177
2006 191
2007 201
2008 280
2009 314
2010 398
2011 399
2012 474
2013 532
2014 652
2015 699
2016 708
2017 795
2018 907
2019 1011
2020 1048
2021 1173
2022 1316
2023 1290
2024 1483
2025 397

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

14,112 results

Results by year

Filters applied: . Clear all
Page 1
Tumor microenvironment as a therapeutic target in cancer.
Xiao Y, Yu D. Xiao Y, et al. Among authors: yu d. Pharmacol Ther. 2021 May;221:107753. doi: 10.1016/j.pharmthera.2020.107753. Epub 2020 Nov 28. Pharmacol Ther. 2021. PMID: 33259885 Free PMC article. Review.
Engineering and Targeting Neutrophils for Cancer Therapy.
Zhang J, Gu J, Wang X, Ji C, Yu D, Wang M, Pan J, Santos HA, Zhang H, Zhang X. Zhang J, et al. Among authors: yu d. Adv Mater. 2024 May;36(19):e2310318. doi: 10.1002/adma.202310318. Epub 2024 Feb 20. Adv Mater. 2024. PMID: 38320755 Review.
Efficacy of a Dengue Vaccine Candidate (TAK-003) in Healthy Children and Adolescents 2 Years after Vaccination.
López-Medina E, Biswal S, Saez-Llorens X, Borja-Tabora C, Bravo L, Sirivichayakul C, Vargas LM, Alera MT, Velásquez H, Reynales H, Rivera L, Watanaveeradej V, Rodriguez-Arenales EJ, Yu D, Espinoza F, Dietze R, Fernando LK, Wickramasinghe P, Duarte Moreira E, Fernando AD, Gunasekera D, Luz K, da Cunha RV, Tricou V, Rauscher M, Liu M, LeFevre I, Wallace D, Kosalaraksa P, Borkowski A. López-Medina E, et al. Among authors: yu d. J Infect Dis. 2022 May 4;225(9):1521-1532. doi: 10.1093/infdis/jiaa761. J Infect Dis. 2022. PMID: 33319249 Free PMC article. Clinical Trial.
Efficacy and safety of low-dose IL-2 in the treatment of systemic lupus erythematosus: a randomised, double-blind, placebo-controlled trial.
He J, Zhang R, Shao M, Zhao X, Miao M, Chen J, Liu J, Zhang X, Zhang X, Jin Y, Wang Y, Zhang S, Zhu L, Jacob A, Jia R, You X, Li X, Li C, Zhou Y, Yang Y, Ye H, Liu Y, Su Y, Shen N, Alexander J, Guo J, Ambrus J, Lin X, Yu D, Sun X, Li Z. He J, et al. Among authors: yu d. Ann Rheum Dis. 2020 Jan;79(1):141-149. doi: 10.1136/annrheumdis-2019-215396. Epub 2019 Sep 19. Ann Rheum Dis. 2020. PMID: 31537547 Free PMC article. Clinical Trial.
14,112 results
You have reached the last available page of results. Please see the User Guide for more information.